Acetazolamide in X-linked Retinoschisis

Phase 2

• Conditions: X-linked Retinoschisis; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12610000476033
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-06-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients with X-linked retinoschisis diagnosis and stable ocular fixation with no clinically significant media opacities.

There will be no age restrictions

Exclusion Criteria

-Hypersensitivity to sulphonamides and sulphonamide derivatives
- Women who are pregnant
- People in existing dependent or unequal relationships
- People highly dependent on medical care
- Aboriginal and/or Torres Striait Islander People
- People who may be involved in illegal activity
- People with an intellectual or mental impairment
- People whose primary language is other than English.
- A refractive error greater than ±6 diopters (D) sphere
- Uveitis
- Optic neuropathy
- The presence of nystagmus or any other retinal diseases affecting the macula other than retinoschisis
- A recent history (<6months) of intraocular surgery, and poor optical coherent tomography (OCT) image quality.

Study & Design

• Study Type: Interventional
• Study Design: Not specified